To conclude, Nrf2 overexpression might inhibit the expression of RFC4 by interacting with the RFC4 promoter and activating the c-Jun/JNK/p65 signaling pathway, resulting in the resistance of AML cells to Ara-C. The gene discussed is RFC4; the disease is acute myeloid leukemia.